WO2012106723A1 - Polyphenol production by vaccinium myrtillus cell cultures - Google Patents
Polyphenol production by vaccinium myrtillus cell cultures Download PDFInfo
- Publication number
- WO2012106723A1 WO2012106723A1 PCT/US2012/024008 US2012024008W WO2012106723A1 WO 2012106723 A1 WO2012106723 A1 WO 2012106723A1 US 2012024008 W US2012024008 W US 2012024008W WO 2012106723 A1 WO2012106723 A1 WO 2012106723A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- vaccinium myrtillus
- suspension
- cell culture
- cell
- Prior art date
Links
- 244000078534 Vaccinium myrtillus Species 0.000 title claims abstract description 124
- 235000017537 Vaccinium myrtillus Nutrition 0.000 title claims abstract description 110
- 238000004113 cell culture Methods 0.000 title claims abstract description 67
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 60
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 60
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 85
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims abstract description 56
- 229920002414 procyanidin Polymers 0.000 claims abstract description 56
- 235000021028 berry Nutrition 0.000 claims abstract description 36
- 238000004114 suspension culture Methods 0.000 claims abstract description 31
- 239000007788 liquid Substances 0.000 claims abstract description 30
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 14
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 14
- 239000004410 anthocyanin Substances 0.000 claims abstract description 14
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 14
- 235000018927 edible plant Nutrition 0.000 claims abstract description 10
- 239000002609 medium Substances 0.000 claims description 59
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 51
- 239000000725 suspension Substances 0.000 claims description 51
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 25
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims description 23
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims description 22
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims description 22
- 241000196324 Embryophyta Species 0.000 claims description 18
- 229930006000 Sucrose Natural products 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 18
- 239000005720 sucrose Substances 0.000 claims description 18
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 16
- 230000012010 growth Effects 0.000 claims description 16
- 238000012258 culturing Methods 0.000 claims description 9
- 239000012737 fresh medium Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000009825 accumulation Methods 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- 235000014633 carbohydrates Nutrition 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 230000004044 response Effects 0.000 claims description 2
- 125000000185 sucrose group Chemical group 0.000 claims description 2
- 239000012134 supernatant fraction Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 97
- 239000000284 extract Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 8
- 241000736767 Vaccinium Species 0.000 description 7
- 230000010261 cell growth Effects 0.000 description 7
- 230000002062 proliferating effect Effects 0.000 description 7
- 239000003643 water by type Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000009470 Theobroma cacao Nutrition 0.000 description 6
- 244000299461 Theobroma cacao Species 0.000 description 6
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 235000012511 Vaccinium Nutrition 0.000 description 5
- 240000001717 Vaccinium macrocarpon Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 230000000977 initiatory effect Effects 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 239000013638 trimer Substances 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 description 4
- 108010007622 LDL Lipoproteins Proteins 0.000 description 4
- 240000000851 Vaccinium corymbosum Species 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 229920002770 condensed tannin Polymers 0.000 description 4
- 239000000539 dimer Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000004323 potassium nitrate Substances 0.000 description 4
- 235000010333 potassium nitrate Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920002330 B type proanthocyanidin Polymers 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 3
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 3
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000021014 blueberries Nutrition 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 235000004634 cranberry Nutrition 0.000 description 3
- 235000007336 cyanidin Nutrition 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- -1 oxygen radical Chemical class 0.000 description 3
- 238000013341 scale-up Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000037351 starvation Effects 0.000 description 3
- 229930013783 (-)-epicatechin Natural products 0.000 description 2
- 235000007355 (-)-epicatechin Nutrition 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 229920001722 A-type proanthocyanidin Polymers 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 2
- 244000077923 Vaccinium vitis idaea Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- LMSNZLCSZWZZGU-UHFFFAOYSA-N butan-1-ol;hydrochloride Chemical compound Cl.CCCCO LMSNZLCSZWZZGU-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Chemical class O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- XFZJEEAOWLFHDH-NFJBMHMQSA-N procyanidin B2 Chemical compound C1([C@@H]2[C@H](O)[C@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-NFJBMHMQSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920002350 Procyanidin B2 Polymers 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 240000008424 Vaccinium ashei Species 0.000 description 1
- 244000177965 Vaccinium lamarckii Species 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 235000011720 Vaccinium uliginosum Nutrition 0.000 description 1
- 235000002422 Vaccinium x intermedium Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 238000002546 full scan Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000004305 normal phase HPLC Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- UONOETXJSWQNOL-UHFFFAOYSA-N tungsten carbide Chemical compound [W+]#[C-] UONOETXJSWQNOL-UHFFFAOYSA-N 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009369 viticulture Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Definitions
- antioxidant compounds scavenge damaging particles known as free radicals in the body, helping to prevent or reverse damage to cells.
- Antioxidants have been shown to help prevent a number of long-term illnesses such as heart disease, cancer, and macular degeneration.
- the V. myrtillus fruit also contains tannins, which are known to act as both an anti-inflammatory and an astringent.
- LDL low density lipoprotein
- macrocarpon Ait. and wild lingonberry contain both A- and B-type procyanidins (Gu et.al., Morimoto et.al., Foo et.al.) whereas primary B-type procyanidins were identified in wild (V. angustifolium Ait.) and cultivated blueberries (V. corymbosum L., V. ashei L.) (Foo et.al; Prior et.
- Vaccinium myrtillus is difficult to grow and is therefore rarely cultivated. As a result, the fruit is generally collected from wild plants during its limited growing season (May through September), which must be both wet and warm. Thus, the supply of the berries is unreliable and the berries are available in limited quantities. Moreover, the fruit are softer and juicier than the related blueberry, such that they must be harvested by hand, and are difficult to transport, which contribute to the high cost of the fresh fruit harvested from the V. myrtillus plant. Also due to the high demand of the ripe fruit, unripe fruits and leaves are not economically viable products to collect. These are the parts of the plant that have highest amounts of the procyanidin. In view of the clinical benefits of V. myrtillus and the difficulty in cultivating these plants, there is a need to develop a sustainable in vitro culture system for the cells of these plants.
- the present disclosure relates to cell culture of Vaccinium myrtillus that are configured to grow in suspension culture in a liquid medium.
- the cells are derived from one or more V. myrtillus plant parts, such as an edible plant part (e.g., a leaf part or a berry part) or a stem part.
- the cells are adapted to grow to a high density in a relatively short period of time (e.g., about 7 days).
- the cells are adapted to produce high concentrations of polyphenols and/or procyanidins and essentially no anthocyanin. Methods for production of polyphenols and procyanidins from Vaccinium myrtillus cells grown in suspension culture are also disclosed.
- a cell culture includes a plurality of friable Vaccinium myrtillus cells in a suspension cell culture.
- the cells in suspension culture are derived from one or more of: a hypocotyl, a cotyledon, a leaf section, a stem section, or a root section of a seedling; or a berry, a stem section including a node or an internode, or a leaf section of a mature plant.
- the cells can be derived from an edible plant part, such as a leaf part or a berry part.
- the cells are selected to be capable of obtaining a packed cell volume of at least 55% in 7 days of growth, wherein at least 10%> of a dry mass of the plurality of Vaccinium myrtillus cells is comprised of polyphenols and at least 5% of a dry mass of the plurality of Vaccinium myrtillus cells is comprised of procyanidins.
- the dry mass of the plurality of Vaccinium myrtillus cells is comprised of polyphenols.
- at least 7.5%, 10%, 15%), 20%), or more of the dry mass of the plurality of Vaccinium myrtillus cells is comprised of procyanidins.
- the mass of cells is essentially free of anthocyanins.
- the dry mass of the plurality of Vaccinium myrtillus cells includes less than 0.5%>, 0.1 %, 0.01%, 0.001%, or less anthocyanin.
- a method of producing a cell culture of Vaccinium myrtillus cells includes (1) producing a cell callus of Vaccinium myrtillus cells derived from one or more of: a hypocotyl, a cotyledon, a leaf section, a stem section, or a root section of a seedling; or a berry, a stem section including a node or an internode, or a leaf section of a mature plant, (2) introducing one or more cells derived from the callus into a liquid medium, (3) agitating the one or more cells in the liquid medium, (4) replacing the liquid medium with a fresh liquid medium or transferring the cells to fresh a fresh liquid medium to establish a suspension cell culture of Vaccinium myrtillus, (5) growing the suspension cell culture of Vaccinium myrtillus to a packed cell volume of at least 55%, and (6) selecting suspension cell cultures having at least 10%) of a dry mass of the plurality of Vaccinium myr
- a method of increasing growth of Vaccinium myrtillus cells in suspension cell culture includes (1) providing a suspension cell culture of Vaccinium myrtillus cells, (2) culturing the cells in a liquid medium in suspension culture, and (3) selecting suspension cell cultures having greater than 45% packed cell volume (PCV).
- PCV packed cell volume
- the method of increasing growth of Vaccinium myrtillus cells in suspension cell culture further includes selecting suspension cell cultures having increased polyphenol and procyanidin accumulation in response to increased sugar concentration in the liquid medium.
- the sugar concentration in the liquid medium includes approximately 30-60 g/L sucrose.
- procyanidin accumulation in the cells in suspension culture is increased from about 1-2 g/L of PCV at 20 g/L sucrose to about 3-7 g/L of PCV at 30 g/L sucrose.
- polyphenol accumulation in the cells in suspension culture is increased from about 2-4 g/L of PCV at 20g/L sucrose to about 5-10 g/L of PCV at 60 g/L sucrose.
- a method of increasing polyphenol production from Vaccinium myrtillus cells in culture includes (1) selecting a plurality of Vaccinium myrtillus cells adapted to grow in suspension culture, (2) and culturing the cells in suspension culture in the presence of a sufficient amount of sugar to increase polyphenol production.
- the sufficient amount of sugar is the liquid medium having greater than 20 g/L sugar, 20 g/L to 30 g/L sugar, or greater than 30 g/L sugar.
- the sugar is sucrose.
- the sugar is glucose.
- the sugar is present in an amount sufficient for polyphenol production to increase above 3 g/L packed cell volume (PCV).
- the sugar is present in an amount sufficient for polyphenol production to increase to at least 7 g/L packed cell volume (PCV).
- a method of extracting polyphenols from Vaccinium myrtillus cells in culture includes (1) selecting a plurality of Vaccinium myrtillus cells adapted to grow in suspension culture, and (2) extracting polyphenols from the cells using a solvent, wherein at least 10% of a dry mass of the plurality of Vaccinium myrtillus cells is comprised of polyphenols and at least 5% of a dry mass of the plurality of Vaccinium myrtillus cells is comprised of procyanidins.
- the solvent includes acetone, acetic acid, and water.
- the solvent includes 70% acetone (v/v) and 0.5%> acetic acid (v/v).
- Figure 1 shows the consumption of sugar with increasing biomass from 25% initial biomass to 50% in one week.
- Figure 2 shows the growth (a) RI (b) and production (c) at different shaker speeds.
- the 500ml flasks were all inoculated at 20% PCV and PCV, RI and production yield was measured after 6 days of growth.
- Figure 3 shows the HPLC chromatogram of extracts from suspension cells derived from stem, hypocotyl, leaf and cotyledon explants in fluorescence detector mode.
- the labels 1 through 12 indicate the degree of polymerization of procyanidins, respectively: 1, monomers; 2, dimers; 3, trimers; 4, tetramers; 5, pentamers; 6, hexamers; 7, heptamers; 8, octamers; 9, nonamers.
- Figure 4 shows the HPLC chromatogram of extracts from suspension cells of Bilberry and cocoa in fluorescence detector mode.
- the labels 1 through 12 indicate the degree of polymerization of procyanidins, respectively: 1, monomers; 2, dimers; 3, trimers; 4, tetramers; 5, pentamers; 6, hexamers; 7, heptamers; 8, octamers; 9, nonamers.
- This figure confirms that the peaks in Bilberry are procyanidin oligomers by the fact that the 2 cell lines were extracted in the same way and are run under same conditions and they have same retention time for each oligomer.
- Figure 5 shows a UV absorption pattern at 280 nm of cocoa (a) and bilberry (b) extracts confirming the presence and detection of procyanidins in Bilberry.
- the present disclosure relates to cell culture of Vaccinium myrtillus that are configured to grow in suspension culture in a liquid medium.
- the cells are derived from one or more V. myrtillus plant parts, such as an edible plant part (e.g., a leaf part or a berry part) or a stem part.
- the cells are adapted to grow to a high density is a relatively short period of time (e.g., about 7 days).
- the cells are adapted to produce high concentrations of polyphenols and/or procyanidins and essentially no anthocyanin.
- Vaccinium myrtillus seeds were obtained from Horizon Herbs, Oregon. Leaves, stem sections and immature berries of V. myrtillus (Erin's Bilberry) used in this Example and the Examples below were collected from National Clonal Germplasm Repository (NCGR) in Corvallis, Oregon.
- NCGR National Clonal Germplasm Repository
- Seeds (Horizon Herbs, Oregon) were surface sterilized by rinsing first, in 75% ethanol for 1 minute. Then they were washed in 25% sodium hypochlorite (v/v) for 15 minutes followed by 5 rinses in sterile distilled water. Seeds were then suspended in 0.1% agarose and plated onto 100 x 25 mm Petri plates (approximately 100 seeds per plate). They were germinated on MS (Murashige and Skoog) medium (4.43 g/L) with 7g/L agar under a 16 hour light and 8 hour dark photoperiod at 23 °C for 4 weeks.
- Example 2 Callus Induction from Vaccinium myrtillus Seedlings Grown In Vitro
- callus produced on media VM1196 and VM1204 both of which had 24 mM ammonium sulfate and 8 mM potassium nitrate but different base salts, (MS basal salts no nitrogen and B5 major salts modified, respectively; Table l) was softer than callus produced on medium with ImM ammonium sulfate and 24 mM potassium nitrate (VM1445).
- Callus produced on medium VM1233 (Madhavi et al., Plant Science, 131 :95-103, 1998) was very compact and non proliferative. Madhavi et al.
- VM1516 gave the most proliferative calli and also helped change the morphology from compact to granular and eventually friable callus. Medium VM1516 also proved the best for sustainably maintaining callus derived from V. myrtillus seedlings. VM1516 was also confirmed to be the best medium for initiating new callus from various V. myrtillus seedling explants, with a success rate of 83%.
- Example 3 Callus induction from Vaccinium myrtillus tissue collected from NCGR
- This example describes methods and media formulations for initiating and maintaining callus from various explants (derived from berries, nodes, internodes, or leaves) derived from field-grown V. myrtillus plants.
- V. myrtillus tissue was subcultured every 3 weeks on VM1516. This callus was very proliferative and friable cell lines were selected for further maintenance. Calli derived from these tissues were maintained on medium VM1516 for over eight months and have demonstrated consistent proliferation without change in quality of the callus.
- Friable cell lines created as in example 2 were chosen for initiation of suspensions.
- Cell suspensions were created by introducing lg (approx) of fresh 2 week old V. myrtillus seedling callus (prepared as in Example 2) into 15 ml of liquid medium (VM1799, VM1831 or DO 151; Table 2) in a sterile 125 ml Erlenmeyer flask. The flasks were covered with sterile silicon (foam) caps and agitated at 120 revolutions per minute (rpm) in a gyrotatory shaker. The suspensions were kept in darkness at 23°C. To establish the cell culture, the spent medium was removed and fresh medium was added every week for 2 subcultures.
- the growth of cells was measured by the rate of carbohydrate consumed by measuring the delta of refractive index (RI) (as measured by degrees of BRIX (i.e., % BRIX)) of the medium. If the RI was less than or equal to half of the initial RI of the medium, fresh medium was added to the cells. If the RI was greater than half, fresh medium was only added after 2 weeks. The subcultures were transferred weekly or biweekly as deemed necessary.
- RI refractive index
- Example 5 Suspension Creation from Callus Derived from Vaccinium myrtillus tissue collected from NCGR
- Friable cell lines were chosen for initiation of suspensions.
- Cell suspensions were created by introducing V. myrtillus callus (prepared as in Example 3 from nodes, internodes, leaves, and berries) into liquid medium (VM1933; Table 2) in sterile Erlenmeyer flasks. The flasks were covered with sterile silicon (foam) caps and agitated at 120 revolutions per minute (rpm) in a gyrotatory shaker. The suspensions were kept in darkness at 25°C. To establish the cell culture, the spent medium was removed and fresh VM1933 medium was added. The growth of cells was measured by the rate of carbohydrate consumed by measuring the delta of refractive index (RI) of the medium. If the RI was less than or equal to half of the initial RI of the medium, fresh medium was added to the cells. If the RI was greater than half, fresh medium was only added after 2 weeks.
- RI refractive index
- This example describes methods used to increase cell growth of suspensions.
- Cell culture productivity increases as a function of the rate of cell growth and the density at which cell growth stops.
- suspension cultures of Vaccinium myrtillus cells were initiated with an inoculum size yielding a starting cell density of 15% packed cell volume ("PCV") and 25% PCV and allowed to grow for 7 days.
- PCV packed cell volume
- Cultures initiated at a cell density of 15% PCV did not reach maximal density within 7 days.
- Cultures initiated at a cell density of 25% PCV in Medium VM1831 (Table 1.) doubled in density (i.e., total cell volume) within 7 days and reached a maximal average cell density of 45-50% PCV within 7 days with some cell line cultures showed over 55-60%> PCV at day 7.
- Cell selection helped to capture cultures that reached a 45%) PCV or more PCV within 7 days or less (a rapidly growing cell culture). Cultures that took more than 7 days to reach 45% PCV were discarded.
- the carbohydrate consumption was rapid in the cultures with the cultures reaching RI of 0 to 0.6 by day 7.
- Polyphenol and/or procyanidin production in VM1831 was low possibly due to sugar starvation.
- the medium VM1831 had 20g/L of sucrose.
- Liquid media was optimized by adjusting carbohydrate level to maintain cultures without nutrient starvation.
- a new medium VM1933 (Tablel .) was formulated with 30g/L of sucrose to avoid sugar starvation of the cells. In this medium the RI went down to between 0.8 and 1.0.
- the production values of polyphenols went up from about 2-4 g/L of PCV at 20g/L sucrose to about 5-10 g/L of PCV at 60 g/L sucrose within 4 subcultures and could be maintained at a high production level.
- the production values of procyanidins went up from about 1-2 g/L of PCV at 20 g/L sucrose to about 3-7 g/L of PCV at 30 g/L sucrose within 4 subcultures and could be maintained at a high production level.
- Example 8 Detection and confirmation of polyphenol and procyanidin production in suspensions from various parts of bilberry seedlings
- This example describes methods developed for extracting polyphenols from callus and suspension cells of Vaccinium cultures developed in examples 1-5.
- Polyphenols were extracted from approximately 0.4 ml of fresh cells from suspensions with 0.4 ml 70% (v/v) acetone with 0.5%> acetic acid.
- a robust high throughput method was used as follows: From each flask of cell culture to be analyzed, the packed cell volume (PCV) of the sample was recorded prior to transferring 0.4 ml into a 96- deep well plate. The supernatant from each well was removed and discarded with a plastic transfer pipette.
- the polyphenols are hydro lyzed to the monomers of (-)-epicatechin and cyanidin by combining 0.1 ml of aqueous acetone extract and 1.0 ml of butanol-HCl reagent (95:5 v/v) and heating the solution at 75 °C for 60 minutes in a Qiagen deep well block (Valencia, CA, USA). Presence of cyanidin in the hydro lyzed sample was observed by the formation of a pink color. The absorbance at 520 nm was determined, and procyanidin content was calculated based on the amount of cyanidin formed using a calibration curve created using different concentrations of procyanidin B2 purchased from Chromadex, Inc. (Irvine, CA). Brighter pink color indicated higher concentration of procyanidins in suspension cultures. Based on this method the procyanidin content of several suspension cultures ranged from lg/L to lOg/L.
- Total polyphenol content of bilberry cell extracts was measured using the Folin-Ciocalteau assay (Slinkard, K.; Singleton,V.L. Total Phenol Analysis: Automation and Comparison with Manual Methods. American Journal of Enology and Viticulture 1977, 28: 49-55).
- Cell culture extracts, in 70% acetone with 0.5%> acetic acid were analyzed for total polyphenol content by taking 25 ⁇ extract and adding it to 0.975 ml of water to dilute the sample prior to beginning the assay.
- 20 ⁇ 1 of the diluted extract is added to 0.790 ml water plus 50 ⁇ of Folin- Ciocalteau reagent.
- the reaction is then stopped by the addition of 150 ⁇ sodium carbonate solution.
- the resulting solution is measured at 765 nm and compared to a calibration curve of various dilutions of gallic acid solution measured by the same assay to determine the concentration of total polyphenols in the cell extracts.
- Example 11 Small scale extraction of polyphenols from fresh bilberry cells or ground freeze dried cells
- Bilberry cells (0.5 mL) without media or 50 mg of ground bilberry cells were sampled in 2.0 ml of micro-tubes or 1.2 ml tubes in a 96 well block from Qiagen, Inc. Appropriate volumes of acidic (0-2% of citric, acetic or ascorbic) aqueous extraction solvent (30-80% of acetone, ethanol, methanol) was added to each of the bilberry cell samples and then placed into ultrasonicator or BeadMill to extract polyphenols and/or procyanidins. The samples were centrifuged for 4 minutes at 6000rpm (RCF 5996). The supernatant may be filtered with 0.45 um membrane filter and diluted to lOx (if necessary) by using the same aqueous extraction solvents prior to analysis. The leftover extracts were stored in -20 degree of freezer for further analyses.
- LC analyses were performed on the Bilberry cell extracts using a Waters (Milford, Massachusetts, USA) Alliance HPLC system equipped with a CTC Analytics PAL autosampler (Leap Technologies, Carrboro, NC, USA), Waters 626 pump with 600S Controller and a Waters 2996 photodiode-array detector (PDA) scanning from 190 to 780nm. Gradient elution was carried out with water-0.1% formic acid (solvent A) and acetonitrile-0.1% formic acid (solvent B) at a constant flow-rate of 0.3 ml/ minute.
- solvent A water-0.1% formic acid
- solvent B acetonitrile-0.1% formic acid
- a linear gradient with the following proportions (v/v) of solvent B was applied (t(min), %B): (0, 7), (5, 15), (20, 75), (25, 100), (35, 100), (35.1, 7) (45, 7).
- the column was Ultra Aqueous C18 column (100 x 2.1 mm i.d., 3.5 ⁇ ) (Restek, Bellefonte, PA. USA).
- the procyanidin monomers of (+)-catechin, (-)-epicatechin, and oligomeric procyanidins (dimer to hexamer) were monitored at 280 nm.
- a Waters Quattro Micro triplequadrupole mass detector (Milford, Massachusetts, USA) was used to obtain the MS data and analyzed by MassLynxTM software. Full-scan data acquisition was performed, scanning from m/z 150 to 1800. Authentic standards for catechin, epicatechin, were purchased from Sigma-Aldrich, Inc. (St. Louis, MO) and dilutions made to create calibration curves in order to detect and quantify the metabolites.
- the binary mobile phase consists of solvent (A), acetonitrile: acetic acid (98:2, v/v) and solvent (B), methanol: water: acetic acid (95:3:2, v/v/v).
- a linear gradient elution was performed at 30 °C with 0.8 mL/min flow rate as follows: 0-35 min, 100-60% A; 35-40 min, 60% A; 40-45 min, 60 - 100%A.
- Separations of oligomer procyanidins were monitored by fluorescence detection (excitation wavelength at 276 nm, emission wavelength at 316 nm), UV detection at 280 nm ( Figure 10A). (Lazarus et al. J. Agric. Food Chem. 47 (1999), 3693) and PDA ( Figure 10B).
- the purpose of the analytical method is to detect the presence of the ten different individual procyanidins in fresh bilberry cells or freeze-dried cells. Detectable procyanidins are monomer, dimmers, trimers, tetramers, pentamers, hexamers, heptamers, octamers, nonamers and decamers.
- a common problem in the use of plant cell cultures is obtaining consistent production of target products (Kim et al., Biotechnol Prog. 20(6) 1666, 2004). Therefore, a key for successful large-scale plant cell culture is to maintain stable productivity.
- a process to scale-up suspensions of bilberry cell cultures from 125 ml flasks to 250mls and then 500ml flasks was successfully conducted.
- the speed of the shakers was optimized for 500 ml flasks to give the same kind of growth and production numbers as in the 125 ml flasks. Three different shaker speeds were tested - 100, 110 and 120 RPM.
- the average PCV was 50 ⁇ 55%> at seven days, which was about 2.5 times greater than the initial PCV level of 20% for all the treatments.
- the production yield (PY) was significantly high at 110 RPM when compared to 100 RPM with a P value of 0.005.
- the difference in PY was not significant between 110 RPM and 120 RPM, the color in the 120 RPM flasks was slightly darker, leading to choose 110 RPM as preferred shaker speed for 500 ml flasks. Every seven days of culture, biomass, sugar concentration in medium, and polyphenol and/or procyanidin productivity, were measured.
- proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry 2000. 54: 173-81.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012800152145A CN103459589A (en) | 2011-02-04 | 2012-02-06 | Polyphenol production by Vaccinium myrtillus cell cultures |
US13/983,537 US20130323843A1 (en) | 2011-02-04 | 2012-02-06 | Polyphenol production by vaccinium myrtillus cell cultures |
EP12742249.1A EP2670247A4 (en) | 2011-02-04 | 2012-02-06 | Polyphenol production by vaccinium myrtillus cell cultures |
AU2012211969A AU2012211969B2 (en) | 2011-02-04 | 2012-02-06 | Polyphenol production by Vaccinium myrtillus cell cultures |
JP2013552721A JP2014504651A (en) | 2011-02-04 | 2012-02-06 | Polyphenol production by Japanese cypress cell culture |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161439675P | 2011-02-04 | 2011-02-04 | |
US61/439,675 | 2011-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012106723A1 true WO2012106723A1 (en) | 2012-08-09 |
Family
ID=46603117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/024008 WO2012106723A1 (en) | 2011-02-04 | 2012-02-06 | Polyphenol production by vaccinium myrtillus cell cultures |
Country Status (6)
Country | Link |
---|---|
US (1) | US20130323843A1 (en) |
EP (1) | EP2670247A4 (en) |
JP (1) | JP2014504651A (en) |
CN (1) | CN103459589A (en) |
AU (1) | AU2012211969B2 (en) |
WO (1) | WO2012106723A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014097977A (en) * | 2012-10-17 | 2014-05-29 | Maruzen Pharmaceut Co Ltd | Tie2 ACTIVATOR, NEOVASCULARIZATION INHIBITOR, BLOOD VESSEL-MATURING AGENT, BLOOD VESSEL-NORMALIZING AGENT, BLOOD VESSEL STABILIZER, AND PHARMACEUTICAL COMPOSITION |
WO2014210391A1 (en) * | 2013-06-26 | 2014-12-31 | Dianaplantsciences, Inc. | Incorporation of cultured bilberry cells in cosmetics, dietary supplements, and/or functional foods |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435078B (en) * | 2014-12-16 | 2018-11-16 | 汤臣倍健股份有限公司 | A kind of composition and its application and preparation |
US20180264060A1 (en) | 2017-03-15 | 2018-09-20 | Tokiwa Phytochemical Co., Ltd. | Composition for preventing, or precaution for dry eye |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102414312A (en) * | 2009-04-03 | 2012-04-11 | 戴安娜植物科学有限公司 | Production and extraction of procyanidins from plant cell cultures |
-
2012
- 2012-02-06 AU AU2012211969A patent/AU2012211969B2/en not_active Expired - Fee Related
- 2012-02-06 US US13/983,537 patent/US20130323843A1/en not_active Abandoned
- 2012-02-06 CN CN2012800152145A patent/CN103459589A/en active Pending
- 2012-02-06 WO PCT/US2012/024008 patent/WO2012106723A1/en active Application Filing
- 2012-02-06 JP JP2013552721A patent/JP2014504651A/en active Pending
- 2012-02-06 EP EP12742249.1A patent/EP2670247A4/en not_active Withdrawn
Non-Patent Citations (4)
Title |
---|
DECENDIT ET AL.: "Galloylated catechins and stilbene diglucosides in Vitis vinifera cell suspension cultures.", PHYTOCHEMISTRY, vol. 60, 2002, pages 795 - 798, XP004373303 * |
MADHAVI ET AL.: "Isolation of bioactive constituents from Vaccinium myrtillus (bilberry) fruits and cell cultures.", PLANT SCIENCE, vol. 131, 1998, pages 95 - 103, XP002082698 * |
See also references of EP2670247A4 * |
YAO ET AL.: "Protective activities of Vaccinium antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity.", NEUROTOXICOLOGY, vol. 28, no. 1, 2007, pages 93 - 100, XP005873669 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014097977A (en) * | 2012-10-17 | 2014-05-29 | Maruzen Pharmaceut Co Ltd | Tie2 ACTIVATOR, NEOVASCULARIZATION INHIBITOR, BLOOD VESSEL-MATURING AGENT, BLOOD VESSEL-NORMALIZING AGENT, BLOOD VESSEL STABILIZER, AND PHARMACEUTICAL COMPOSITION |
JP2017190355A (en) * | 2012-10-17 | 2017-10-19 | 丸善製薬株式会社 | Tie 2 activator, angiogenesis inhibitor, blood vessel maturation agent, blood vessel normalization agent, blood vessel stabilizer, and food and drink |
WO2014210391A1 (en) * | 2013-06-26 | 2014-12-31 | Dianaplantsciences, Inc. | Incorporation of cultured bilberry cells in cosmetics, dietary supplements, and/or functional foods |
Also Published As
Publication number | Publication date |
---|---|
EP2670247A1 (en) | 2013-12-11 |
CN103459589A (en) | 2013-12-18 |
US20130323843A1 (en) | 2013-12-05 |
AU2012211969B2 (en) | 2016-04-21 |
JP2014504651A (en) | 2014-02-24 |
AU2012211969A1 (en) | 2013-08-15 |
EP2670247A4 (en) | 2014-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ali et al. | Production of commercially important secondary metabolites and antioxidant activity in cell suspension cultures of Artemisia absinthium L. | |
JP5789595B2 (en) | Production and extraction of procyanidins from plant cell cultures | |
Karam et al. | Growth and rosmarinic acid accumulation in callus, cell suspension, and root cultures of wild Salvia fruticosa | |
Yuan et al. | Anthocyanins, phenolics, and antioxidant capacity of Vaccinium L. in Texas, USA | |
US9167840B2 (en) | Production and extraction of procyanidins from plant cell cultures | |
US8617621B2 (en) | Composition for enhancing immunity containing plant stem cell line derived from cambium of Panax ginseng including wild ginseng or ginseng as an active ingredient | |
Yildirim et al. | Effects of regeneration enhancers on micropropagation of Fragaria vesca L. and phenolic content comparison of field-grown and in vitro-grown plant materials by liquid chromatography-electrospray tandem mass spectrometry (LC–ESI-MS/MS) | |
AU2012211969B2 (en) | Polyphenol production by Vaccinium myrtillus cell cultures | |
Kumar et al. | In vitro propagation and phyto-chemical assessment of Cymbidium aloifolium (L.) Sw.: An orchid of pharma-horticultural importance | |
CN112996799A (en) | Composition for protecting nerve cells comprising naphthopyrone derivative derived from sprout of cassia seed | |
Ekiert et al. | High production of depsides and other phenolic acids in different types of shoot cultures of three aronias: Aronia melanocarpa, Aronia arbutifolia, Aronia× prunifolia | |
Karcheva-Bahchevanska et al. | Therapeutic effects of anthocyannins from Vaccinium genus L | |
KR20210145186A (en) | Phyto complexes and selected extracts of meristem cell lines of plants belonging to the genus Melissa | |
Kaur et al. | Phenolic compounds from peel and callus extracts of sweet lime (Citrus medica) | |
Angulo-Bejarano et al. | Nopal: a perspective view on its nutraceutical potential | |
Domínguez et al. | Production of honokiol and magnolol in suspension cultures of Magnolia dealbata Zucc | |
Smith | Vaccinium species (small-fruited berries): in vitro culture and the production of food colorants and phytochemicals | |
KR102678647B1 (en) | method of producing viniferin and pterostilbene from blueberry | |
Tocci | Hypericum perforatum subsp. angustifolium: study of xanthone biosynthesis in planta and in in vitro systems | |
ZAINUDDIN et al. | Edible Seed of Kluwek (Pangium Edule) as Natural Sources of Antioxidant and Antibacterial Compounds. | |
Soliman et al. | Evaluation of In Vitro Germination and Callus Induction for Antimicrobial Activities of Jatropha curcas L. | |
KR20200011238A (en) | method of producing viniferin and pterostilbene from blueberry | |
Tsalokostas | Using tissue culture as an alternative source of polyphenols produced by Ficus carica L. | |
US20110054195A1 (en) | Synchronized strains of subepidermal cells of muscadine (muscadine sp.) grapevine pericarp for use as a sourse of flavonoids (nutraceuticals) | |
YAZAKI¹ et al. | XI Hypericum erectum Thunb.(St. John's Wort): In Vitro Culture and the Production of Procyanidins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12742249 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2013552721 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2012211969 Country of ref document: AU Date of ref document: 20120206 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13983537 Country of ref document: US |
|
REEP | Request for entry into the european phase |
Ref document number: 2012742249 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012742249 Country of ref document: EP |